SARcode Bioscience

SARcode Biosciences SARcode is a privately held biotechnology company headquartered in San Francisco, focusing on the development of small molecule LFA-1 antagonists for the treatment of inflammatory diseases. Targets include localized treatments for T cell-mediated ophthalmic and dermatological conditions, including dry eye disease, diabetic retinopathy, eczema, and psoriasis.